Mobilization of CD34+ hematopoietic progenitor cells in SCID beige mice utilizing flow cytometer

被引：0
|
作者：
Zong, Q. [1 ]
Vitsky, A. [1 ]
Yafawi, R. [1 ]
Ko, M. [1 ]
Sace, F. [1 ]
Malamant, M. [1 ]
John-Baptiste, A. [1 ]
机构：
[1] Pfizer Inc, PGRD, San Diego, CA USA
来源：
CLINICAL CHEMISTRY | 2008年 / 54卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
D142
引用
收藏
页码：A189 / A189
页数：1
相关论文
共 50 条
  • [21] DEVELOPING A MICROENVIRONMENT FOR THE DIFFERENTIATION OF PRIMITIVE CD34+ HEMATOPOIETIC-CELLS IN HU-BM-SCID MICE
    RITCHEY, DW
    HALL, ER
    KAUSHAL, S
    LARUSSA, V
    KESSLER, S
    GARTNER, S
    STLOUIS, DC
    MAYERS, D
    PERERA, LP
    YU, ZP
    KIM, JH
    SITZ, K
    XU, J
    BURKE, DS
    MOSCA, JD
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1994, : 234 - 234
  • [22] Histopathology and Biodistribution in NCG Mice Engrafted with Mobilized CD34+ Human Hematopoietic Stem and Progenitor Cells
    Smutova, Viktorija
    Moreno, Angela Holguin
    Gains, Malcolm
    Para, Camila
    Spickler, Catherine
    Riffon, Renee
    Hung, Selly
    Rowe, Jenny
    Festin, Steve
    Authier, Simon
    Hoberman, Alan M.
    INTERNATIONAL JOURNAL OF TOXICOLOGY, 2023, 42 (01) : 92 - 92
  • [23] Lenalidomide-induced upregulation of CXCR4 in CD34+ hematopoietic cells, a potential mechanism of decreased hematopoietic progenitor mobilization
    S Li
    J Fu
    H Ma
    M Y Mapara
    S Lentzsch
    Leukemia, 2013, 27 : 1407 - 1411
  • [24] Lenalidomide-induced upregulation of CXCR4 in CD34+ hematopoietic cells, a potential mechanism of decreased hematopoietic progenitor mobilization
    Li, S.
    Fu, J.
    Ma, H.
    Mapara, M. Y.
    Lentzsch, S.
    LEUKEMIA, 2013, 27 (06) : 1407 - 1411
  • [25] Induction of apoptosis by chemotherapeutic drugs on CD34+/CD38+and CD34+/CD38-hematopoietic progenitor cells.
    Chow, KU
    Stieler, M
    Martin, H
    Rummel, MJ
    Weidmann, E
    Hoelzer, D
    Mitrou, PS
    BLOOD, 1999, 94 (10) : 154B - 154B
  • [26] No proinflammatory signature in CD34+ hematopoietic progenitor cells in multiple sclerosis patients
    Lutterotti, A.
    Jelcic, I.
    Schulze, C.
    Schippling, S.
    Breiden, P.
    Mazzanti, B.
    Reinhardt, S.
    DiGioia, M.
    Repice, A.
    Massacesi, L.
    Sputtek, A.
    Salinas-Riester, G.
    Kroeger, N.
    Sospedra, M.
    Saccardi, R.
    Zander, A.
    Martin, R.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 (08) : 1188 - 1192
  • [27] EX-VIVO EXPANSION OF HUMAN CD34+ HEMATOPOIETIC PROGENITOR CELLS
    FEL, R
    HEIMFELD, S
    XU, Z
    FOGARTY, B
    JONES, HM
    THOMPSON, P
    BERENSON, RJ
    EXPERIMENTAL HEMATOLOGY, 1994, 22 (08) : 726 - 726
  • [28] Highly efficient gene transfer into preterm CD34+ hematopoietic progenitor cells
    Shields, LE
    Kiem, HP
    Andrews, RG
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2000, 183 (03) : 732 - 737
  • [29] Immunophenotypic characteristics of PB-mobilised CD34+ hematopoietic progenitor cells
    Menéndez, P
    del Cañizo, MC
    Orfao, A
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2001, 15 (01): : 53 - 61
  • [30] RETINOIC ACID INDUCES APOPTOSIS IN HUMAN CD34+ HEMATOPOIETIC PROGENITOR CELLS
    JOSEFSEN, D
    BLYSTAD, AK
    LOMO, J
    KIIL, BH
    SMELAND, EB
    EXPERIMENTAL HEMATOLOGY, 1995, 23 (08) : 814 - 814
12345